Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
ASND — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

4.62

Margin Of Safety %

-25

Put/Call OI Ratio

0.59

EPS Next Q Diff

EPS Last/This Y

14.25

EPS This/Next Y

-1.18

Price

266.47

Target Price

304.98

Analyst Recom

1.18

Performance Q

7.47

Upside

-36.1%

Beta

0.38

Ticker: ASND



22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-14ASND227.180.471.0712473
2026-10-15ASND226.490.4611.3712427
2026-10-16ASND225.050.471.9312546
2026-10-19ASND228.590.540.189253
2026-10-20ASND234.280.521.609591
2026-10-21ASND238.840.521.399600
2026-10-22ASND242.790.520.909629
2026-10-23ASND243.270.521.339674
2026-10-26ASND244.150.520.089690
2026-10-27ASND245.940.521.059795
2026-10-28ASND249.860.540.529856
2026-10-29ASND252.950.571.0410094
2026-10-30ASND251.040.590.1810131
2026-11-02ASND248.870.590.1410135
2026-11-03ASND250.280.591.6710141
2026-11-04ASND258.060.590.4010142
2026-11-05ASND253.270.590.2110145
2026-11-06ASND256.770.580.4410253
2026-11-09ASND259.680.580.0810275
2026-11-10ASND255.590.580.5910311
2026-11-11ASND259.210.581.6810389
2026-11-12ASND267.020.590.6010495
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1



22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-14ASND227.07- 615.212.79
2026-10-15ASND226.54- 613.112.79
2026-10-16ASND225.24- 594.212.79
2026-10-19ASND229.76- 614.612.79
2026-10-20ASND229.76- 614.612.79
2026-10-21ASND234.16- 630.712.79
2026-10-22ASND243.05- 609.812.79
2026-10-23ASND243.19- 595.412.79
2026-10-26ASND245.26- 600.412.79
2026-10-27ASND245.99- 596.811.32
2026-10-28ASND249.76- 610.211.32
2026-10-29ASND253.04- 603.510.08
2026-10-30ASND251.12- 585.810.08
2026-11-02ASND248.95- 584.010.08
2026-11-03ASND249.91- 586.610.08
2026-11-04ASND257.95- 614.310.08
2026-11-05ASND253.31- 574.610.08
2026-11-06ASND256.77- 601.110.08
2026-11-09ASND259.77- 601.110.08
2026-11-10ASND256.56- 579.210.08
2026-11-11ASND259.10- 598.510.08
2026-11-12ASND266.47- 615.310.08
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1



21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-14ASND-2.490.945.37
2026-10-15ASND-2.490.945.37
2026-10-16ASND-2.490.945.37
2026-10-19ASND-2.490.995.37
2026-10-20ASND-2.490.995.37
2026-10-21ASND-2.490.995.37
2026-10-22ASND-2.490.995.37
2026-10-23ASND-2.490.995.37
2026-10-26ASND-2.491.065.37
2026-10-27ASND-2.491.064.83
2026-10-28ASND-2.491.064.83
2026-10-29ASND-2.491.064.83
2026-10-30ASND-2.491.064.83
2026-11-02ASND-2.491.094.83
2026-11-03ASND-2.491.094.83
2026-11-05ASND-2.491.094.83
2026-11-06ASND-2.491.094.83
2026-11-09ASND-2.491.574.83
2026-11-10ASND-2.491.574.83
2026-11-11ASND-2.491.574.62
2026-11-12ASND-2.491.574.62
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

1.12

Avg. EPS Est. Next Quarter

1.42

Insider Transactions

-2.49

Institutional Transactions

1.57

Beta

0.38

Average Sales Estimate Current Quarter

365

Average Sales Estimate Next Quarter

410

Fair Value

199.02

Quality Score

96

Growth Score

Sentiment Score

80

Actual DrawDown %

5.6

Max Drawdown 5-Year %

Target Price

304.98

P/E

20.35

Forward P/E

26.34

PEG

P/S

14.37

P/B

10.68

P/Free Cash Flow

45.11

EPS

13.12

Average EPS Est. Cur. Y​

10.08

EPS Next Y. (Est.)

8.9

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

70.99

Relative Volume

1.72

Return on Equity vs Sector %

25.2

Return on Equity vs Industry %

44.7

EPS 1 7Days Diff

-2.7

EPS 1 30Days Diff

-2.71

EBIT Estimation

615.3
◆ ASND Healthcare
$267.07
📉
Swing / Pullback
Buy the dip on strong trends
46 /100
WEAK
Trend
20/20
Pullback
6/25
Volume
3/15
Valuation
10/20
TP/AR
2/10
Options
5/10
RSI
70.2
Range 1M
93.9%
Sup Dist
4.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
51 /100
WEAK
Momentum
13/25
Growth
19/30
Estimates
3/20
Inst/Vol
8/15
Options
8/10
EPS Yr
485.6%
EPS NY
-36.9%
52W%
83.8%
💎
Long-Term Value
Quality companies, undervalued
53 /100
WEAK
🔴 SELL -33.2% upside
Quality
29/30
Valuation
2/30
Growth
11/25
Stability
7/10
LT Trend
4/5
Upside
-33.2%
Quality
96
MoS
-25%
Click a card to see score breakdown Full Analysis →
ASND — P/E HistoricalBiotechnology
Ascendis Pharma A/S
Sector: Healthcare
Industry: Biotechnology
Employees: 1189
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
ASND

Latest News

—
Caricamento notizie per ASND…
stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today
news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025
marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance
stock history ASND – Ascendis Pharma A/S invest stock market
stock prices ASND premarket after hours
ticker ASND fair value insiders trading